PYXS vs LAWR
Comparison between Pyxis Oncology Inc (PYXS, Company) and Robot Consulting Co. Ltd (LAWR, Company).
PYXS is from the Healthcare sector, while LAWR is from the Industrials sector.
PYXS vs LAWR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
PYXS
$159M
LAWR
$158M
Max Drawdown
PYXS
93.57%
Winner
LAWR
56.99%
Sharpe Ratio
Winner
PYXS
1.32
LAWR
0.52
5Y Beta
PYXS
1.35
Winner
LAWR
-0.17
Industry
PYXS
Biotechnology
LAWR
Consulting Services
P/E Ratio
PYXS
-1.93
Winner
LAWR
-44.38
5Y EPS CAGR
PYXS
N/A
LAWR
-1.84%
Debt to Equity
PYXS
0.00%
LAWR
0.00%
Free Cash Flow Yield
PYXS
-42.13%
Winner
LAWR
-1.22%
P/S Ratio
PYXS
11.57
Winner
LAWR
0.27
P/B Ratio
PYXS
4.53
LAWR
N/A
PYXS vs LAWR - Historical Returns
Returns include dividend reinvestment.
1M
Winner
PYXS
+27.62%
LAWR
+0.00%
3M
Winner
PYXS
+56.73%
LAWR
+0.00%
6M
Winner
PYXS
+64.42%
LAWR
+0.00%
1Y
Winner
PYXS
+127.12%
LAWR
+19.05%
5Y(CAGR)
PYXS
-28.32%
LAWR
N/A
Max(CAGR)
PYXS
-28.32%
Winner
LAWR
+6.43%
PYXS vs LAWR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | PYXS | LAWR |
|---|---|---|
| 2026 | +133.04% | +0.00% |
| 2025 | -31.95% | +6.53% |
| 2024 | -24.27% | N/A |
| 2023 | +30.43% | N/A |
| 2022 | -88.28% | N/A |
| 2021 | -16.89% | N/A |
PYXS vs LAWR Drawdown Comparison
The maximum drawdown for PYXS was -93.57%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for LAWR was -56.99%, occurring on Aug 6, 2025. Recovery took 65 trading sessions.
The current PYXS drawdown is -80.35%.
| Rank | PYXS | LAWR |
|---|---|---|
| #1 | -93.57% Nov 4, 2021 - Apr 8, 2025 | -56.99% Jul 18, 2025 - Oct 20, 2025 |
| #2 | -12.95% Oct 8, 2021 - Oct 28, 2021 | -1.87% Oct 20, 2025 - Oct 21, 2025 |
| #3 | -1.05% Oct 29, 2021 - Nov 3, 2021 | N/A |
Correlation
Correlation between PYXS and LAWR is 0.36 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.36
-101
Select Stocks to Compare
Popular: PYXS vs SPYLAWR vs SPY
More Comparisons
Compare with similar stocks